Samuel Bates Martin, SVP AND CFO at Celldex Therapeutics, Inc. (CLDX), sold 35,000 shares at $34.05 ($1.2M) on 2024-05-30, disclosed to the SEC on 2024-06-03.
Open-market sale of $1.2M CLDX by SVP AND CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CLDX | SELL | 2021-12-28 | $399K | — | Filing → |
| CLDX | SELL | 2021-11-17 | $828K | — | Filing → |
| CLDX | SELL | 2021-08-12 | $124K | — | Filing → |